CDTX vs GEN · rev $1.3M vs P/E 17, rev $5.00B
Cidara Therapeutics Inc (CDTX) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
CDTX currently screens at market cap $6.96B. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the CDTX and GEN stock pages for the full models.
Not investment advice.